Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-02-15

Clinical Trial Update: Vitamin C and Liraglutide Effects on Hypoglycemia-induced Oxidative Stress, Inflammation and Endothelial Dysfunction in Type 1 Diabetes. [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating vitamin C and liraglutide for hypoglycemia-related oxidative stress, inflammation, and endothelial dysfunction in Type 1 diabetes was…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin C (ascorbic acid)
  • liraglutide (liraglutide)

Snippet

Sponsor: Anna Cruceta | Conditions: Type 1 Diabetes Mellitus | Phase 1 | Status: WITHDRAWN